OBJECTIVE: To examine the expression of toll-like receptors (TLR) by primary human Fallopian tube epithelial cells (FTEC) and to determine whether exposure to the TLR3 agonist poly(I:C) induces an antiviral response. DESIGN: Tissue culture study. SETTING: University medical center. PATIENT(S): Premenopausal women undergoing hysterectomy. INTERVENTION(S): Primary human FTEC were grown to confluence and high transepithelial resistance and treated with TLR agonists. Conditioned media was collected and RNA was extracted and analyzed for the expression of cytokines, chemokines, and antimicrobial genes. MAIN OUTCOME MEASURE(S): The RNA was analyzed by real-time polymerase chain reaction and protein levels were assessed by enzyme-linked immunosorbent assay. RESULT(S): The FTEC were demonstrated to express TLR1-9 but not 10. Treatment of FTEC with TLR3 agonist poly(I:C) resulted in increased expression of interleukin-8, tumor-necrosis factor alpha, human beta-defensin 2, interferon beta, and interferon stimulated genes myxovirus resistance gene 1, 2',5'-oligoadenylate synthetase, and protein kinase R. Additionally, FTEC exposed to poly(I:C) also resulted in the induction of TLR2, TLR3, and TLR7. CONCLUSION(S): Our results suggest that FTEC are sensitive to viral infection and/or exposure to viral double-stranded RNA and can respond by secreting proinflammatory cytokines that mediate the initiation of an inflammatory response as well as expressing genes that can directly inhibit viral replication.
OBJECTIVE: To examine the expression of toll-like receptors (TLR) by primary human Fallopian tube epithelial cells (FTEC) and to determine whether exposure to the TLR3 agonist poly(I:C) induces an antiviral response. DESIGN: Tissue culture study. SETTING: University medical center. PATIENT(S): Premenopausal women undergoing hysterectomy. INTERVENTION(S): Primary human FTEC were grown to confluence and high transepithelial resistance and treated with TLR agonists. Conditioned media was collected and RNA was extracted and analyzed for the expression of cytokines, chemokines, and antimicrobial genes. MAIN OUTCOME MEASURE(S): The RNA was analyzed by real-time polymerase chain reaction and protein levels were assessed by enzyme-linked immunosorbent assay. RESULT(S): The FTEC were demonstrated to express TLR1-9 but not 10. Treatment of FTEC with TLR3 agonist poly(I:C) resulted in increased expression of interleukin-8, tumor-necrosis factor alpha, humanbeta-defensin 2, interferon beta, and interferon stimulated genes myxovirus resistance gene 1, 2',5'-oligoadenylate synthetase, and protein kinase R. Additionally, FTEC exposed to poly(I:C) also resulted in the induction of TLR2, TLR3, and TLR7. CONCLUSION(S): Our results suggest that FTEC are sensitive to viral infection and/or exposure to viral double-stranded RNA and can respond by secreting proinflammatory cytokines that mediate the initiation of an inflammatory response as well as expressing genes that can directly inhibit viral replication.
Authors: Dekai Zhang; Guolong Zhang; Matthew S Hayden; Matthew B Greenblatt; Crystal Bussey; Richard A Flavell; Sankar Ghosh Journal: Science Date: 2004-03-05 Impact factor: 47.728
Authors: Miguel E Quiñones-Mateu; Michael M Lederman; Zhimin Feng; Bikram Chakraborty; Jan Weber; Hector R Rangel; Michael L Marotta; Muneer Mirza; Bin Jiang; Patti Kiser; Kathy Medvik; Scott F Sieg; Aaron Weinberg Journal: AIDS Date: 2003-11-07 Impact factor: 4.177
Authors: Kelly D Smith; Erica Andersen-Nissen; Fumitaka Hayashi; Katie Strobe; Molly A Bergman; Sara L Rassoulian Barrett; Brad T Cookson; Alan Aderem Journal: Nat Immunol Date: 2003-11-16 Impact factor: 25.606
Authors: Louise A Duits; Peter H Nibbering; Elisabeth van Strijen; Joost B Vos; Sylvia P G Mannesse-Lazeroms; Marianne A J A van Sterkenburg; Pieter S Hiemstra Journal: FEMS Immunol Med Microbiol Date: 2003-08-18
Authors: Scott H Randell; Toni Darville; Uma M Nagarajan; Bryan E McQueen; Amy Kiatthanapaiboon; M Leslie Fulcher; Mariam Lam; Kate Patton; Emily Powell; Avinash Kollipara; Victoria Madden; Robert J Suchland; Priscilla Wyrick; Catherine M O'Connell; Boris Reidel; Mehmet Kesimer Journal: Infect Immun Date: 2020-08-19 Impact factor: 3.441
Authors: D Omagari; N Takenouchi-Ohkubo; S Endo; T Ishigami; A Sawada; I Moro; M Asano; K Komiyama Journal: Clin Exp Immunol Date: 2011-04-19 Impact factor: 4.330
Authors: Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira Journal: PLoS One Date: 2010-06-29 Impact factor: 3.240
Authors: Mimi Ghosh; Zheng Shen; John V Fahey; Sarah G Crist; Mickey Patel; Jennifer M Smith; Charles R Wira Journal: Am J Reprod Immunol Date: 2012-09-17 Impact factor: 3.886